HealthQuill Articles by: HealthQuill
Covid-19 US Depression
Drugs Health Medical

Syphilis cases in the US surge to 70-year high: CDC

HQ Team February 2, 2024: The Centers for Disease Control (CDC) reports that syphilis cases in the United States have reached their highest

Read More
Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to treat hypertension in people with high cardiovascular risk.
Drugs Health Medical

Molecular coating on X chromosomes may explain higher autoimmune susceptibility in women

Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases

Read More
Climate Health Pharma

Urban farms offer promise in reducing carbon footprints with sustainable strategies

Bharti Jayshankar February 2, 2024: As urban farming gains momentum as a solution to environmental and health challenges, a recent international collaboration delves

Read More
A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the University of Florida.
Drugs Health Medical

Boosting cardiorespiratory fitness lowers prostate cancer risk, study finds

HQ Team February 1, 2024: Cardio exercise can play a role in lowering the incidence of prostate cancer, according to new research. The

Read More
Drugs Medical Pharma

Promising new treatment on the horizon for ALS

HQ Team February 1, 2024: Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease is a rare neurodegenerative disorder affecting both upper

Read More
Philips’ recalled ventilators and machines for treating obstructive sleep apnea have caused 561 deaths, according to the USFDA.
Drugs Health Medical

Philips faulty ventilators, machines cause 561 deaths, says USFDA

Philips’ recalled ventilators and machines for treating obstructive sleep apnea have caused 561 deaths, according to the USFDA.

Read More
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed to rope in a partner to cut costs of obtaining standard regulatory approval.
Drugs Health Pharma

Biogen abandons Alzheimer’s drug Aduhelm to focus on Leqembi

Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed

Read More
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
Drugs Health Pharma

Scientists’ eye easy diagnosis for adenomyosis condition in women

Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.

Read More
The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for Palestine refugees that is being accused by Israel of participation in the October 7 attacks.
Drugs Health Pharma

Palestine refugees’ fate hangs in balance as UN chief meets donor nations

The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for

Read More
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according to a WHO report.
Drugs Health Pharma

Cancer cases set to rise by 77% to 35 million in 2050: WHO global survey

More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according

Read More